The administration of FVIII or FIX by continuous infusion generally offers a more constant level of protection and usually reduces the costs of treatment [12], especially in patients with severe haemophilia, but jit requires a separate intravenous line dedicated to this drug. Here, F8 is linked to hemophilia.